Evaluating The Relation Between Serum (Apolipoprotein B, A, Apo B/Apo A Ratio) And Diabetic Retinopathy in Sample of Type 2 Egyptian Diabetic Patient | ||
| Egyptian Society of Diabetes and Lipidology Journal | ||
| Volume 2, Issue 1, April 2022 PDF (68.07 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/esdlj.2022.455708 | ||
| Abstract | ||
| Diabetic retinopathy (DR) is a chronic progressive, potentially sight-threatening disease of the retinal microvasculature associated with prolonged hyperglycemia and other conditions linked to diabetes mellitus such as hypertension. Most studies to date have shown no association between the traditional serum lipid markers (serum total cholesterol, triglycerides, low density lipoproteins (LDL), and high density lipoproteins (HDL) and DR. novel serum lipid markers( Apo lipoproteins) which are the protein portion of lipoproteins (Apo- A, Apo-B and Apo-B/Apo-A ratio)were recently linked to DR, and observed that the increase in serum Apo-B and high Apo-B /Apo-A ratio associated with increased risk of proliferative diabetic retinopathy. | ||
|
Statistics Article View: 1 |
||
